Home › B-Cell Leukemia › Illinois › Chicago
B-Cell Leukemia clinical trials in Chicago, IL
3 studies for B-Cell Leukemia are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
B-Cell Leukemia trials in other cities
- Houston, TX7 studies
- Dallas, TX5 studies
- Washington, DC5 studies
- Columbus, OH4 studies
- Portland, OR4 studies
- Louisville, KY3 studies
- Spokane, WA3 studies
- Clifton, NJ3 studies
- Charlotte, NC3 studies
- New York City, NY3 studies
- San Diego, CA3 studies
- Philadelphia, PA3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)52 studies
- Prostate Cancer45 studies
- Metastatic Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer37 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight27 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.